Skip to main content

Table 2 Assessment on the methodological strategies of the included studies

From: Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – an updated systematic review and meta-analysis

Trial IDRandom sequence generationAllocation concealmentBlindingIncomplete outcome dataSelective outcome reportingOther sources of bias
Uwe Reuter 2018Low riskLow riskLow riskLow riskLow riskUnclear risk
David W Dodick 2017Low riskLow riskLow riskLow riskLow riskUnclear risk
Peter J. Goadsby 2017Low riskLow riskLow riskLow riskLow riskUnclear risk
Hong Sun 2016Low riskLow riskLow riskLow riskLow riskUnclear risk
David W Dodick 2014Low riskLow riskLow riskLow riskLow riskUnclear risk
David W. Dodick 2018Low riskLow riskLow riskLow riskLow riskUnclear risk
Marcelo E Bigal 2015Low riskLow riskLow riskLow riskLow riskUnclear risk
Vladimir Skljarevski 2018Low riskLow riskLow riskLow riskLow riskUnclear risk
Vladimir Skljarevski 2017Low riskLow riskLow riskLow riskLow riskUnclear risk
Virginia L. Stauffer 2018Low riskLow riskLow riskLow riskLow riskUnclear risk
David W Dodick 2014Low riskLow riskLow riskLow riskLow riskUnclear risk